In the light of the rapid and recent falls from grace of companies such as British Biotech (Oxford, UK) and Cortecs (Isleworth, UK), the UK trade organization the BioIndustry Association proposed a code of conduct on July 8 that urges companies to seek external advice both on matters that have to be disclosed to shareholders and on scientific/clinical affairs. BIA plans to "name and shame" transgressors and, if necessary, revoke their membership of the association (Nature Biotechnol., 17, 12).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hodgson, J. BIA drafts code of practice. Nat Biotechnol 17, 737 (1999). https://doi.org/10.1038/11637
Issue Date:
DOI: https://doi.org/10.1038/11637